MnSOD乙酰化对肾透明细胞癌786-O细胞增殖、凋亡的影响
Effect of MnSOD acetylation on the proliferation and apoptosis of clear cell renal cell carcinoma cell line 786-O

DOI: 10.6040/j.issn.1671-7554.0.2016.1604

Keywords: 靶向治疗,肾透明细胞癌,锰型超氧化物歧化酶,去乙酰化酶,活性氧自由基,
Manganese superoxide dismutase,Deacetylase,Clear cell renal cell carcinoma,Reactive oxygen species,Targeted therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Wang S, Shu J, Chen L, et al. Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus[J]. Onco Targets Ther, 2016, 9: 6381-6388. doi:10.2147/OTT.S113014.
[2]	Park KC, Heo JH, Jeon JY, et al. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio)hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells[J]. BMC Cancer, 2015, 15(1): 19. doi: 10.1186/s12885-014-1003-1.
[3]	Ramakrishnan S, Ellis L, Pili R. Histone modifications: implications in renal cell carcinoma[J]. Epigenomics, 2013, 5(4): 453-462.
[4]	Hemachandra LP, Shin DH, Dier U, et al. Mitochondrial superoxide dismutase has a protumorigenic role in ovarian clear cell carcinoma[J]. Cancer Res, 2015, 75(22): 4973-4984.
[5]	Pandit H, Zhang W, Li Y, et al. Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma[J]. Cancer Gene Ther, 2015, 22(10): 481-486.
[6]	Zhao Z, Wu F, Ding S, et al. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma[J]. Tumour Biol, 2015, 36(2): 939-951.
[7]	Dhar SK, St Clair DK. Manganese superoxide dismutase regulation and cancer[J]. Free Radic Biol Med, 2012, 52(11-12): 2209-2222.
[8]	Cui Y, Qin L, Wu J, et al. SIRT3 enhances glycolysis and proliferation in SIRT3-expressing gastric cancer cells[J]. PLoS One, 2015, 10(6): e0129834. doi: 10.1371/journal.pone.0129834.
[9]	Sun GG, Hu WN, Wang YD, et al. Bidirectional regulation of manganese superoxide dismutase(MnSOD)on the radiosensitivity of esophageal cancer cells[J]. Asian Pac J of Cancer Prev, 2012, 13(7): 3015-3023.
[10]	Ding S, Zhao Z, Sun D, et al. Eg5 inhibitor, a novel potent targeted therapy, induces cell apoptosis in renal cell carcinoma[J]. Tumour Biol, 2014, 35(8): 7659-7668.
[11]	Vidimar V, Gius D, Chakravarti D, et al. Dysfunction MnSOD leads to redox dysregulation and activity of prosurvival AKT signaling in uterine leiomyomas[J]. Sci Adv, 2016, 2(11): e1601132. doi:10.1126/sciadv.1601132.
[12]	Tao R, Coleman MC, Pennington JD, et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress[J]. Mol Cell, 2010, 40(61): 893-904.
[13]	Chen Y, Zhang J, Lin Y, et al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS[J]. EMBO Reports, 2011, 12(6): 534-541.
[14]	Qiu X, Brown K, Hirschey MD, et al. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation[J]. Cell Metab, 2010, 12(6): 662-667.
[15]	赵佳,姚创利,左林,等. 冠心病患者血清同型半胱氨酸对血脂和锰超氧化物歧化酶的影响[J]. 现代检验医学杂志, 2015,30(5): 44-49. ZHAO Jia, YAO Chuangli, ZUO Lin, et al. Effects of homocysteine on blood lipid and manganese superoxide dismutase in patients with coronary heart disease[J]. J Mod Lab Med, 2015, 30(5): 44-49.
[16]	Huang P, Feng L, Oldham EA, et al. Superoxide dismutase as a target for the selective killing of cancer cells[J]. Nature, 2000, 407(6802): 390-395.

Full-Text